Published in Virulence on November 01, 2010
Bacteria tracking by in vivo magnetic resonance imaging. BMC Biol (2013) 0.87
Real-time bioluminescence imaging of mixed mycobacterial infections. PLoS One (2014) 0.84
New directions using reporter enzyme fluorescence (REF) as a tuberculosis diagnostic platform. Tuberculosis (Edinb) (2016) 0.79
Animal Models for Tuberculosis in Translational and Precision Medicine. Front Microbiol (2017) 0.75
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med (2000) 13.69
A clearer vision for in vivo imaging. Nat Biotechnol (2001) 10.49
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Photonic detection of bacterial pathogens in living hosts. Mol Microbiol (1995) 5.24
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A (2000) 4.25
Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science (1998) 4.15
Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun (2000) 3.62
Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun (2001) 3.28
Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis (1967) 3.00
Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science (2004) 2.58
A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39
Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother (1973) 2.33
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother (1996) 1.94
Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother (1996) 1.88
Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics. Antimicrob Agents Chemother (2006) 1.70
Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol (2005) 1.59
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A (2010) 1.51
Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia (2006) 1.45
EFGP and DsRed expressing cultures of Escherichia coli imaged by confocal, two-photon and fluorescence lifetime microscopy. FEBS Lett (2000) 1.42
Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J Clin Microbiol (1993) 1.38
Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther (2007) 1.23
Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett (2002) 1.19
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Microbes Infect (2009) 1.09
Cell-permeable near-infrared fluorogenic substrates for imaging beta-lactamase activity. J Am Chem Soc (2005) 1.00
Fitness cost of the green fluorescent protein in gastrointestinal bacteria. Can J Microbiol (2003) 0.98
Realization of beta-lactamase as a versatile fluorogenic reporter. Trends Biotechnol (2004) 0.95
Optimization of GFP levels for analyzing Salmonella gene expression during an infection. FEBS Lett (2002) 0.94
Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261. Microb Pathog (1994) 0.91
Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells. J Gene Med (2006) 0.85
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A (2010) 1.51
Genetic and phenotypic differences between Legionella pneumophila strains. J Clin Microbiol (2002) 1.41
Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence. Microb Biotechnol (2008) 1.38
Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin. J Nanobiotechnology (2012) 1.28
Molecular properties and antibacterial activity of the methyl and ethyl ester derivatives of ampicillin. Physiol Chem Phys Med NMR (2004) 1.23
Pseudomonas aeruginosa PAO1 virulence factors and poplar tree response in the rhizosphere. Microb Biotechnol (2008) 1.21
Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection. Proc Natl Acad Sci U S A (2007) 1.13
A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos. Mol Microbiol (2011) 1.10
Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Mol Microbiol (2011) 1.08
Role of the Legionella pneumophila rtxA gene in amoebae. Microbiology (2002) 1.06
A humanized mouse model of tuberculosis. PLoS One (2013) 1.03
Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat Chem (2012) 1.01
Protection of Mycobacterium tuberculosis from reactive oxygen species conferred by the mel2 locus impacts persistence and dissemination. Infect Immun (2009) 1.00
Identification of a gene that affects the efficiency of host cell infection by Legionella pneumophila in a temperature-dependent fashion. Infect Immun (2003) 0.99
Evidence that hsp90 is involved in the altered interactions of Acanthamoeba castellanii variants with bacteria. Eukaryot Cell (2004) 0.97
Non-opsonic phagocytosis of Legionella pneumophila by macrophages is mediated by phosphatidylinositol 3-kinase. PLoS One (2008) 0.96
Identification of Mycobacterium marinum macrophage infection mutants. Microb Pathog (2006) 0.95
Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium. Infect Immun (2005) 0.95
Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2011) 0.93
A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species. Infect Immun (2006) 0.93
The Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species. BMC Microbiol (2007) 0.89
Application of optical imaging to study of extrapulmonary spread by tuberculosis. Tuberculosis (Edinb) (2009) 0.89
Identification of two Mycobacterium marinum loci that affect interactions with macrophages. Infect Immun (2004) 0.88
Whole-body imaging of infection using fluorescence. Curr Protoc Microbiol (2011) 0.87
Using luciferase to image bacterial infections in mice. J Vis Exp (2011) 0.86
Infection of murine macrophage cell lines by Legionella pneumophila. FEMS Microbiol Lett (2004) 0.85
Whole-body imaging of infection using bioluminescence. Curr Protoc Microbiol (2011) 0.84
The EAL domain containing protein STM2215 (rtn) is needed during Salmonella infection and has cyclic di-GMP phosphodiesterase activity. Mol Microbiol (2013) 0.83
Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci. Infect Immun (2008) 0.83
Fluorogenic probes with substitutions at the 2 and 7 positions of cephalosporin are highly BlaC-specific for rapid Mycobacterium tuberculosis detection. Angew Chem Int Ed Engl (2014) 0.82
Design of ciprofloxacin derivatives that inhibit growth of methicillin resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA). Med Chem (2010) 0.81
Mycobacterium tuberculosis interferes with the response to infection by inducing the host EphA2 receptor. J Infect Dis (2009) 0.80
Fiber optic microendoscopy for preclinical study of bacterial infection dynamics. Biomed Opt Express (2011) 0.80
Small molecule hydrazide agents to inhibit growth and proliferation of mycobacterium tuberculosis. Med Chem (2012) 0.79
Entry into host cells by Legionella. Front Biosci (2002) 0.77
Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities. Biotechnol Appl Biochem (2003) 0.77
Random inducible controlled expression (RICE) for identification of mycobacterial virulence genes. Tuberculosis (Edinb) (2011) 0.76
Antibacterial activity of dipeptide constructs of acetylsalicylic acid and nicotinic acid. Drug Deliv (2007) 0.75
Four hydrazide compounds that inhibit the growth of mycobacterium tuberculosis. Physiol Chem Phys Med NMR (2008) 0.75
Derivatives of cephalothin that inhibit ampicillin resistant Escherichia coli. Med Chem (2007) 0.75
Efficacy of using sutures treated with povidone-iodine or chlorhexidine for preventing growth of Staphylococcus and Escherichia coli. Plast Reconstr Surg (2009) 0.75
Virulent mycobacteria and the many aspects of macrophage uptake. Future Microbiol (2007) 0.75